Actively Recruiting
Study to Evaluate Blood Protein Thrombomodulin for Detecting Giant Cell Arteritis in Patients Over 50 with Polymyalgia Rheumatica
Led by Centre Hospitalier Universitaire Dijon · Updated on 2025-09-09
78
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Polymyalgia rheumatica PMR is a condition affecting people over 50, causing inflammation and pain in the shoulder and hip areas. Sometimes PMR occurs with giant cell arteritis GCA, a disease affecting large blood vessels, which can cause headaches, vision problems, and other symptoms. GCA can also be present without symptoms, especially when it affects large vessels only. This study aims to find blood markers, specifically thrombomodulin, that can help distinguish between isolated PMR and PMR with GCA, potentially reducing the need for additional imaging or biopsies.
CONDITIONS
Brief Title
Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ)
Research Team
A
André RAMON
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
